CA2292628A1 - Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride - Google Patents

Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride Download PDF

Info

Publication number
CA2292628A1
CA2292628A1 CA002292628A CA2292628A CA2292628A1 CA 2292628 A1 CA2292628 A1 CA 2292628A1 CA 002292628 A CA002292628 A CA 002292628A CA 2292628 A CA2292628 A CA 2292628A CA 2292628 A1 CA2292628 A1 CA 2292628A1
Authority
CA
Canada
Prior art keywords
cisapride
dosage form
tablet
solid dosage
tartrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002292628A
Other languages
English (en)
Inventor
Paul Marie Victor Gilis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2292628A1 publication Critical patent/CA2292628A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002292628A 1997-06-11 1998-06-04 Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride Abandoned CA2292628A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP97201768 1997-06-11
EP97201767.7 1997-06-11
EP97201767 1997-06-11
EP97201768.5 1997-06-11
PCT/EP1998/003495 WO1998056364A1 (fr) 1997-06-11 1998-06-04 Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride

Publications (1)

Publication Number Publication Date
CA2292628A1 true CA2292628A1 (fr) 1998-12-17

Family

ID=26146581

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002292628A Abandoned CA2292628A1 (fr) 1997-06-11 1998-06-04 Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride

Country Status (6)

Country Link
EP (1) EP0988032A1 (fr)
JP (1) JP2002504107A (fr)
KR (1) KR20010012104A (fr)
AU (1) AU7919398A (fr)
CA (1) CA2292628A1 (fr)
WO (1) WO1998056364A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2324475C2 (ru) * 2001-04-10 2008-05-20 Сан Фармасьютикал Индастриз Лимитед Состав, выделяемый в импульсном режиме в заданное время
CA2561700A1 (fr) * 2004-04-16 2005-12-15 Santarus, Inc. Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique
US20130084313A1 (en) * 2011-09-30 2013-04-04 Stomavite, Llc Supplement for ostomy patients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2139638A1 (fr) * 1992-07-07 1994-01-20 Nancy M. Gray Methodes d'utilisation de la (-) cisapride pour le traitement du reflux gastro-oesophagien et d'autres troubles
EP0651639A4 (fr) * 1992-07-07 1996-06-26 Sepracor Inc Procedes d'utilisation de cisapride (+) pour le traitement du reflux gastro- sophagien et d'autres troubles.
EP0707492A1 (fr) * 1993-07-06 1996-04-24 Merck & Co. Inc. Combinaisons d'agents anti-h 2? et d'agents de motilite gastro-intestinale
DK0670160T3 (da) * 1994-03-01 2000-02-14 Gerhard Gergely Granulært præparat eller tablet omfattende et brusemiddel og et aktivt farmaceutisk stof samt fremgangsmåde til dets fremst
CH686865A5 (de) * 1994-06-15 1996-07-31 Gergely Gerhard Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
EP0803251B1 (fr) * 1996-04-23 2002-07-17 Janssen Pharmaceutica N.V. Formes solides d'administration de cisapride à libération immédiate et indépendente du PH

Also Published As

Publication number Publication date
WO1998056364A1 (fr) 1998-12-17
KR20010012104A (ko) 2001-02-15
JP2002504107A (ja) 2002-02-05
EP0988032A1 (fr) 2000-03-29
AU7919398A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
US6030988A (en) Immediate release pH-independent solid dosage form of cisapride
JP4573397B2 (ja) 速崩壊性固形製剤
JP5002044B2 (ja) 錠剤の製造方法
EP0922464B1 (fr) Materiaux moules par compression, a desagregation rapide, et leur procede de production
AU2002320385B2 (en) Sequential drug delivery systems
US9492541B2 (en) Phenylepherine containing dosage form
CN107028900A (zh) 快速分散颗粒、口腔崩解片以及方法
JP2009114113A (ja) 口腔内崩壊錠及びその製造方法
MXPA04000223A (es) Formas de dosis de bencimidazol substituidas novedosas y metodo para usar las mismas.
TWI240638B (en) A film-coated solid-dosage form pharmaceutical composition
KR100846945B1 (ko) 파라세타몰을 포함하는 연하 정제
WO2019130749A1 (fr) Nouveau revêtement de microparticules (particules creuses comprenant un médicament et procédé de fabrication de celles-ci)
JP5138856B2 (ja) 錠剤の製造方法
EP0803251B1 (fr) Formes solides d'administration de cisapride à libération immédiate et indépendente du PH
JP2021138689A (ja) 錠剤、その製造方法、および医薬品
CA2292628A1 (fr) Forme galenique solide a liberation immediate independante du ph de (+)- ou (-)-cisapride
WO2010087358A1 (fr) Nouvelle composition
US9364451B1 (en) Alternating sympathomimetic therapy for the treatment of respiratory ailments
MXPA98008710A (en) Dosage form solid independent of the ph, of immediate release
US20210346303A1 (en) Coating method
WO2014027974A1 (fr) Formulation de palipéridone à désintégration orale
HK1018399A (en) Immediate release ph-independent solid dosage form of cisapride
Konde Formulation and Evaluation of Orodispersible Tablets of Lansoprazole

Legal Events

Date Code Title Description
FZDE Dead